230 related articles for article (PubMed ID: 37511864)
1. Transarterial Embolization and Percutaneous Ablation of Primary and Metastatic Soft Tissue Tumors.
Shu C; Lim M; Fang A
Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511864
[TBL] [Abstract][Full Text] [Related]
2. Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer.
Mansur A; Garg T; Camacho JC; Habibollahi P; Edward Boas F; Khorshidi F; Buethe J; Nezami N
Technol Cancer Res Treat; 2023; 22():15330338231164193. PubMed ID: 36942407
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous bone lesion ablation.
Filippiadis DK; Tutton S; Kelekis A
Radiol Med; 2014 Jul; 119(7):462-9. PubMed ID: 24894924
[TBL] [Abstract][Full Text] [Related]
4. Interventional radiology for hepatocellular carcinoma.
Loffroy R
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous ablation of hepatic tumors.
McCarley JR; Soulen MC
Semin Intervent Radiol; 2010 Sep; 27(3):255-60. PubMed ID: 22550364
[TBL] [Abstract][Full Text] [Related]
6. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
[TBL] [Abstract][Full Text] [Related]
7. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
[TBL] [Abstract][Full Text] [Related]
8. Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors.
Yu H; Burke CT
Semin Intervent Radiol; 2014 Jun; 31(2):129-37. PubMed ID: 25071303
[TBL] [Abstract][Full Text] [Related]
9. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma.
Razi M; Jianping G; Xu H; Ahmed MJ
J Interv Med; 2021 Feb; 4(1):11-14. PubMed ID: 34805941
[TBL] [Abstract][Full Text] [Related]
10. [Primary tumors of the liver: radiologic interventional procedures].
Pereira PL; Schmidt D; Trübenbach J; König CW; Viebahn R; Claussen CD
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():194-9. PubMed ID: 11824245
[TBL] [Abstract][Full Text] [Related]
11. [Interventional Radiology in Oncology - Update 2021].
Henze J; Maintz D
Dtsch Med Wochenschr; 2021 Aug; 146(15):966-970. PubMed ID: 34344031
[TBL] [Abstract][Full Text] [Related]
12. Locoregional Therapies of Cholangiocarcinoma.
Sommer CM; Kauczor HU; Pereira PL
Visc Med; 2016 Dec; 32(6):414-420. PubMed ID: 28229076
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
[TBL] [Abstract][Full Text] [Related]
14. Interventional oncology: new techniques and new devices.
Breuer JA; Ahmed KH; Al-Khouja F; Macherla AR; Muthoka JM; Abi-Jaoudeh N
Br J Radiol; 2022 Sep; 95(1138):20211360. PubMed ID: 35731848
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?
Seinstra BA; van Delden OM; van Erpecum KJ; van Hillegersberg R; Mali WP; van den Bosch MA
Insights Imaging; 2010 Jul; 1(3):167-81. PubMed ID: 23100194
[TBL] [Abstract][Full Text] [Related]
16. Interventional radiology for the treatment of hepatic malignancy.
Islam MN; Azad SA; Karim E; Rahman SM; Khan NA
Mymensingh Med J; 2012 Apr; 21(2):377-90. PubMed ID: 22561791
[TBL] [Abstract][Full Text] [Related]
17. Intraarterial Therapies for the Management of Hepatocellular Carcinoma.
Garg T; Shrigiriwar A; Habibollahi P; Cristescu M; Liddell RP; Chapiro J; Inglis P; Camacho JC; Nezami N
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884412
[TBL] [Abstract][Full Text] [Related]
18. Single-session transarterial chemoembolization combined with percutaneous thermal ablation in liver metastases 3 cm or larger.
Kobe A; Tselikas L; Deschamps F; Roux C; Delpla A; Varin E; Hakime A; De Baère T
Diagn Interv Imaging; 2022 Nov; 103(11):516-523. PubMed ID: 35715327
[TBL] [Abstract][Full Text] [Related]
19. Metastatic disease to the liver: Locoregional therapy strategies and outcomes.
Zane KE; Cloyd JM; Mumtaz KS; Wadhwa V; Makary MS
World J Clin Oncol; 2021 Sep; 12(9):725-745. PubMed ID: 34631439
[TBL] [Abstract][Full Text] [Related]
20. Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status.
Qian K; Zhang F; Allison SK; Zheng C; Yang X
J Interv Med; 2021 Feb; 4(1):1-7. PubMed ID: 34805939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
